Fischer Medical Ventures Limited has informed the Exchange about General Updates
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited announced its unaudited financial results for the quarter ended June 30, 2025, at a board meeting held on August 14, 2025. On a standalone basis, the company posted revenue from operations of Rs 454.23 lakhs for Q1 FY26 (vs nil in Q1 FY25) but swung to a loss of Rs 60.94 lakhs from a profit of Rs 83.94 lakhs a year ago. On a consolidated basis, revenue rose to Rs 1,152.83 lakhs from Rs 1,012.07 lakhs, and the company turned to a profit of Rs 500.82 lakhs versus a loss of Rs 11.71 lakhs in Q1 FY25, with EPS of Rs 0.36. The board also fixed the 32nd AGM for September 29, 2025, via video conferencing, and approved a 5-year appointment for the secretarial auditor. Independent Director Dr. Jacob Thomas resigned effective close of business on August 14, 2025, citing personal reasons.
The consolidated turnaround to profit is a positive signal, but the standalone business slipped into loss, which investors may view as mixed. The independent director's resignation is administrative and unlikely to move the stock, though watch for any further board changes.